Blood glycome possibly predicts lifespan
What if a routine blood test could reveal the long-term risk of death, not by measuring cholesterol or glucose, but by identifying sugars attached to blood proteins? In a recent study published in Molecular & Cellular Proteomics, Iago Carballo of the University of Santiago de Compostela and an international team showed that total serum N-glycome can predict mortality in a general adult population, independent of traditional risk factors.
The researchers analyzed blood samples from 1,516 randomly selected adult participants enrolled in the A-Estrada Glycation and Inflammation Study, or AEGIS, cohort in Spain and followed participants for a median of 7.5 years to record mortality. The team analyzed the total serum N-glycome, which represents all glycans attached to serum proteins, by grouping glycans with similar structures and chemical properties into quantifiable glycome peaks or GPs. They found that individuals with higher levels of GP16 and lower levels of GP22 were significantly more likely to die during the follow-up period.
GP associations remained robust after accounting for age, sex and established clinical risk factors. Distinct glycan patterns were also linked to cancer-related and cardiovascular mortality, suggesting that serum protein glycosylation reflects underlying biological processes related to these conditions. The findings highlight serum N-glycan profiles as a promising complement to existing risk prediction tools for identifying individuals at elevated risk earlier in life.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Glaucoma model links immune signaling to disease progression
Researchers at Duke University determine genetic variations that could increase the risk of developing glaucoma.
Uncovering the molecular roots of fatty liver disease
Physician–scientist Silvia Sookoian discusses her path from hepatitis C care to MASLD research, her use of multi-omics to study steatotic liver disease, and how lipid metabolism and genetics are reshaping understanding of MASH and liver health.
Mitochondria shape kidney cell function
Researchers at the University of Washington, Seattle present the first quantitative comparison of mitochondrial interactomes between two epithelial cell types in the kidney.
Long-chain polyunsaturated fatty acids linked to postoperative delirium risk
Researchers show that altered lipid metabolism may contribute to postoperative delirium, a condition linked to increased risk for long-term cognitive decline. The study explores potential disease mechanisms, which have yet to be understood.
Glycosylation patterns across antibody isotypes distinguish tuberculosis states
Researchers at Taipei Medical University present the first site-specific glycosylation analysis of immunoglobulins in elderly tuberculosis patients.
Building a better model for drug delivery across the blood–brain barrier
Industry and academic scientists collaborated to develop a rat with humanized iron-transport receptors, enabling research into iron homeostasis and drugs that cross the brain’s barrier.